Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00FAY
|
|||
| Former ID |
DNC009669
|
|||
| Drug Name |
4-(3-thienyl)benzene-1,2-diamine)
|
|||
| Synonyms |
SCHEMBL3568658
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H10N2S
|
|||
| Canonical SMILES |
C1=CC(=C(C=C1C2=CSC=C2)N)N
|
|||
| InChI |
1S/C10H10N2S/c11-9-2-1-7(5-10(9)12)8-3-4-13-6-8/h1-6H,11-12H2
|
|||
| InChIKey |
OZEWMDJTNVDPJN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated potassium channel Kv11.1 (KCNH2) | Target Info | Inhibitor | [1] |
| Pathwhiz Pathway | Muscle/Heart Contraction | |||
| Reactome | Voltage gated Potassium channels | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Hematopoietic Stem Cell Differentiation | ||||
| Potassium Channels | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1168-72. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.